News
Webinar: Insight Synthesis and Delivery Using AI - 19 March 2026
Showcasing where AI can genuinely make a difference in insight synthesis and delivery.
Insight Synthesis and Delivery Using AI is a practical, insight led webinar designed for pharma insights managers who want to move beyond surface level AI use and unlock real strategic value.
This members only session explores:
The current reality of AI adoption in pharma insights
Where AI delivers the biggest impact today
You can now sign up for the 2024 Basel chapter meeting on 19 September 2024
‘Analysing the impact of Health Inequality: Unravelling the Business Question’
Meeting Convenors:
Ana Maria Aguirre-Arteta, Novartis
Our Devices and Diagnostics Group meets to discuss and explore the specific needs of manufacturers and agencies working in the area of medical device and diagnostics.
The group comprises of both industry and agency members who are currently developing a directory of agencies with expertise in Devices and Diagnostics.
As we look back at the 2024 EPHMRA Conference, we would like to take the chance to thank our Conference exhibitors for a wonderful agency fair.
Here are the members who took the opportunity to exhibit:
- elma research
- Fine Research
- groupH
- Instar
- KeyQuest Health
- Mayland Research
- MCI (Medical Collective Intelligence)
As an EPHMRA member, you’ll be supported throughout all stages of your career.
We aim to strengthen your core competencies through continuous professional development so you can achieve excellence as a business partner of choice.
Exclusive members-only training is developed by our Learning and Development Committee and includes access to a comprehensive training programme delivered online.
As the dust settles on 2024 EPHMRA Conference... we just want to say it was great to see everyone in London this week.
What can we say... great papers, great discussions and everyone enjoyed meeting up.
We just wanted to extend a huge thankyou from EPHMRA to our 2024 Conference Convenors…
Our Data and Systems Committee works with secondary information providers to ensure quality global data is available to help you and your company make the right decisions.
Passionate about secondary data, our D&S Committee influences global systems development by liaising with providers on improving statistical quality and coverage.
Our Classification Committee is responsible for the Anatomical Classification system (ATC) including new classes reflecting market developments and new chemical entities (NCEs).
The classification system enables you to define the market and competition so you can measure the impact of new entrants and ensure alignment with WHO regulations.
The Classification Committee will support you by:
See Paul Griffiths, Client Advocates present his paper...
‘How Agencies and Pharma clients can collaborate to make sure that research and insight is seen as an investment, rather than a cost’ at the 2024 EPHMRA conference.
The biggest determinant of your health is your postcode.
Multiple studies have highlighted various factors that contribute to healthcare inequalities, with policymakers, charities, and patient groups committed to addressing the determinants of variation in outcomes.